The aging lower urinary tract

Journal of Urology

Volumn 175, Issue 3 SUPPL., 2006, Pages

  DuBeau, Catherine E ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b MC6098 ^*  (United States)

Author keywords

Aged; Bladder; Polypharmacy; Urinary incontinence; Urination disorders

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPHENHYDRAMINE; DIURETIC AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; OPIATE; OXYBUTYNIN; TOLTERODINE;

AGING; AMNESIA; ARTHRITIS; BEHAVIOR THERAPY; BLURRED VISION; COGNITIVE DEFECT; COMORBIDITY; CONFUSION; CONGESTIVE HEART FAILURE; CONSTIPATION; DELIRIUM; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DIAGNOSTIC TEST; HUMAN; HYDROCEPHALUS; MEDICAL LITERATURE; MINI MENTAL STATE EXAMINATION; NOCTURIA; OSTEOARTHRITIS; PARKINSON DISEASE; POLYPHARMACY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SLEEP APNEA SYNDROME; STROKE; URINARY TRACT DISEASE; URINE INCONTINENCE; XEROSTOMIA;

EID: 31744445383     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)00311-3     Document Type: Article

References (25)

1. M. Toossi A century of change the U. S. labor force, 1950-2050 Mon Labor Rev 2002
2. I. Milsom, P. Abrams, L. Cardozo, R.G. Roberts, J. Thuroff, A.J. Wein How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study BJU Int 87 2001 760
3. A. Haferkamp, A. Elbadawi Ultrastructural changes in the aging bladder Urologe A 43 2004 527
4. A. Elbadawi, S.V. Yalla, N.M. Resnick Structural basis of geriatric voiding dysfunction. III. Detrusor overactivity J Urol 150 1993 1668
5. N.M. Resnick, A. Elbadawi, S.V. Yalla Age and the lower urinary tract what is normal? Neurourol Urodyn 14 1995 577
6. J. Nordling The aging bladder-a significant but underestimated role in the development of lower urinary tract symptoms Exp Gerontol 37 2002 991
7. N.M. Resnick, S.V. Yalla Detrusor hyperactivity with impaired contractile function. An unrecognized but common cause of incontinence in elderly patients JAMA 257 1987 3076
8. J.G. Forsberg A morphologist's approach to the vagina-age-related changes and estrogen sensitivity Maturitas 22 suppl. 1995 S7
9. A. Carlile, I. Davies, A. Rigby, J.C. Brocklehurst Age changes in the human female urethra a morphometric study J Urol 139 1988 532
10. M. Verelst, J.M. Maltau, A. Orbo Computerised morphometric study of the paraurethral tissue in young and elderly women Neurourol Urodyn 21 2002 529
11. D. Perucchini, J.O. DeLancey, J.A. Ashton-Miller, A. Galecki, G.N. Schaer Age effects on urethral striated muscle. II. Anatomic location of muscle loss Am J Obstet Gynecol 186 2002 356
12. J.D. McConnell, M.J. Barry, R.C. Bruskewitz Benign Prostatic Hyperplasia Diagnosis and Treatment Agency for Health Care Policy and Research Publication No. 94-0582 1994 Agency for Health Care Policy and Research Rockville, Maryland
13. P. Abrams, L. Cardozo, M. Fall, D. Griffiths, P. Rosier, U. Ulmsten The standardisation of terminology in lower urinary tract function report from the standardisation sub-committee of the International Continence Society Urology 61 2003 37
14. M.F. Folstein, S.E. Folstein, P.R. McHugh "Mini-mental state" A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189
15. P. Abrams, L. Cardozo, S. Khoury, A. Wein Incontinence 3rd International Consultation on Incontinence 2005 Health Publication Ltd Plymouth, United Kingdom
16. N.M. Resnick, G.H. Brandeis, M.M. Baumann, J.N. Morris Evaluating a national assessment strategy for urinary incontinence in nursing home residents reliability of the minimum data set and validity of the resident assessment protocol Neurourol Urodyn 15 1996 583
17. Detrol LA® package insert 2004 Pharmacia and Upjohn Co Kalamazoo
18. Ditropan XL® package insert 2004 Ortho-McNeil Pharmaceutical Raritan
19. Vesicare® package insert 2004 Yamanouchi Pharma America Paramus
20. Enablex® package insert 2004 Novartis Pharmaceuticals Corp East Hanover, New Jersey
21. I.R. Katz, L.P. Sands, W. Bilker, S. DiFilippo, A. Boyce, K. D'Angelo Identification of medications that cause cognitive impairment in older people the case of oxybutynin chloride J Am Geriatr Soc 46 1998 8
22. J.G. Ouslander, C. Maloney, T.H. Grasela, L. Rogers, C.A. Walawander Implementation of a nursing home urinary incontinence management program with and without tolterodine J Am Med Dir Assoc 2 2001 207
23. K.B. Womack, K.M. Heilman Tolterodine and memory dry but forgetful Arch Neurol 60 2003 771
24. E.L. Siegler, M. Reidenberg Treatment of urinary incontinence with anticholinergics in patients taking cholinesterase inhibitors for dementia Clin Pharmacol Ther 75 2004 484
25. A. Todorova, B. Vonderheid-Guth, W. Dimpfel Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system J Clin Pharmacol 41 2001 636